• ASCP Action Alert Targets CMS.

    August 16, 2013
    ASCP recently urged you to contact Congress about the Centers for Medicare and Medicaid Services’ (CMS) proposed cuts in reimbursement for essential pathology and laboratory services. This follow-up alert now asks you to urge CMS to abandon these harmful cuts in pathology and laboratory payment rates Read more
  • ePolicy News June 2013

    June 01, 2013
    ASCP to Congress: Repeal SGR, Fix Stark and Meaningful Use
    Earlier this month, ASCP advocated that the powerful U.S. House of Representatives Ways & Means and Energy & Commerce Committees, both of which have oversight over Medicare, repeal the Medicare Physician Fee Schedule’s flawed Sustainable Growth Rate (SGR). This advocacy was in response to a recent joint committee report recommending the repeal and reform of the SGR, the flawed formula used to calculate the annual update in the Medicare Physician Fee Schedule. Read more
  • ePolicy News May 2013

    May 02, 2013
    Supreme Court Considers Validity of Gene Patents
    The United States Supreme Court heard arguments last month in Association for Molecular Biology v. Myriad Genetics, Inc., et al, the landmark lawsuit challenging whether isolated human genes are patentable. The case questions Myriad Genetics’ right to patent BRCA1 and BRCA2, two genes that correlate to increased rates of breast and ovarian cancer. Read more